Search for: "Sandoz, Inc. "
Results 421 - 440
of 598
Sorted by Relevance
|
Sort by Date
7 Nov 2014, 9:17 am
Sandoz, wherein there was no stipulation for the purposes of seeking an appeal. [read post]
20 Jan 2011, 12:50 pm
Sandoz Pharmaceuticals Corp., 487 S.E.2d 70, 74 (Ga. [read post]
5 Jul 2013, 5:00 am
Squibb and Sons, Inc. v. [read post]
18 Apr 2017, 6:52 am
., Inc. v. [read post]
28 Jun 2016, 6:41 am
(post-sale restrictions); and Sandoz v. [read post]
9 Apr 2009, 7:52 am
(IP Think Tank) Brazilian public-private partnerships in the pharma industry (IP tango) EU: ECJ to rule on reference on SPC Regulation interpretation from Lithuania in Kirin Amgen, Inc. v Lietuvos Respublikos valstybinis patentų biuras (The SPC Blog) India: Delhi High Court Dasatinib order: Is patent-drug regulatory linkage a necessity? [read post]
7 Apr 2010, 4:30 am
Sandoz Pharmaceuticals GmbH et al (EPLAW) Prilosec (Omeprazole) – US: AstraZeneca ordered to pay attorney’s fees for ‘baseless’ suit to protect Prilosec OTC: AstraZeneca AB et al. v. [read post]
1 May 2008, 11:21 am
Beretta USA, Inc., No. 05-6942-cv (2d Cir. [read post]
18 Feb 2010, 10:34 am
Mylan followed Sandoz Pharmaceuticals Corp. v. [read post]
4 Aug 2010, 12:21 am
Roxane Laboratories Inc. [read post]
26 Jun 2008, 6:31 pm
Matkari, 7 F.3d 1130, 1139 (4th Cir. 1993); Sandoz Pharmaceuticals v. [read post]
22 Aug 2013, 1:34 pm
Loryna, a generic version of YAZ, and Syeda, a generic version of Yasmin, are made and sold by Sandoz, Inc. [read post]
8 Apr 2010, 9:48 am
Sandoz Pharmaceuticals Corp., 131 F. [read post]
5 Sep 2016, 6:46 pm
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Biologics Notice of Commercial Marketing: Sandoz Inc. v. [read post]
3 Jun 2016, 6:40 am
Seagate, No. 15-1285 (pre-invention assignment of future patent rights) Biologics Notice of Commercial Marketing: Sandoz Inc. v. [read post]
18 May 2016, 8:19 am
Seagate, No. 15-1285 (pre-invention assignment of future patent rights) Biologics Notice of Commercial Marketing: Sandoz Inc. v. [read post]
25 May 2009, 5:20 pm
(The IP Factor) Israel Patent Office practice regarding legal expenses in oppositions (The IP Factor) New Zealand New Zealand launches second ACTA consultation (Michael Geist) United Kingdom EWHC request for summary judgment denied - OHIM-IPO class heading conflict case: Daimler v Sany (IPKat) United States US General Trade secret litigation on the rise against laid off employees (Silicon Valley IP Licensing Law Blog) Seeking and justifying attorney fee awards may be… [read post]
3 May 2016, 1:42 am
Seagate, No. 15-1285 (pre-invention assignment of future patent rights) Biologics Notice of Commercial Marketing: Sandoz Inc. v. [read post]
15 May 2014, 9:36 am
Sandoz Pharms. [read post]
8 May 2009, 8:00 am
(Property intangible) US: Supreme Court rules 9-0 that CAFC has jurisdiction to review case remanded by district court to state court: Carlsbad Technology Inc v HIF Bio, Inc et al (Managing Intellectual Property) (Patently-O) US: Anticipation by a laundry list of prophetic DNA sequences: In re Gleave (Holman's Biotech IP Blog) US: Reverse payment settlements and biotechnology (Holman's Biotech IP Blog) US: Biogen seeks review and correction of patent term adjustment… [read post]
